ProductsBack/ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]

ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]

Name: ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]
SKU: GTX01452_G10
Availability: BackOrder

GTX01452

ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

ReactivityHuman, Mouse, Rat, Yeast

TargetMapk3

Overview

Supplier
GeneTex
Product Name
ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]
Delivery Days Customer
9
Application Supplier Note
WB: 0.25-0.5microg/ml. ICC/IF: 1microg/ml. IHC-P: 0.4-1microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
MAPK-YT
Conjugate
Unconjugated
Gene ID50689
Target name
Mapk3
Target description
mitogen activated protein kinase 3
Target synonyms
ERK1, ERT2, Erk-1, Esrk1, MAPK1, MNK1, Prkm3, p44, p44erk1, p44mapk, mitogen-activated protein kinase 3, MAP kinase 1, MAP kinase 3, MAPK 1, MAPK 3, extracellular signal-regulated kinase 1, insulin-stimulated MAP2 kinase, microtubule-associated protein 2 kinase, mitogen-activated 3, mitogen-activated protein kinase 1
Host
Mouse
Isotype
IgG1
Protein IDP21708
Protein Name
Mitogen-activated protein kinase 3
Reactivity
Human, Mouse, Rat, Yeast
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Domínguez-Martínez DA, Fontes-Lemus JI, García-Regalado A, et al. IL-8 Secreted by Gastric Epithelial Cells Infected with Helicobacter pylori CagA Positive Strains Is a Chemoattractant for Epstein-Barr Virus Infected B Lymphocytes. Viruses. 2023,15(3). doi: 10.3390/v15030651
Read this paper
Zhu Z, Yu W, Fu X, et al. Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2015,34(1):95. doi: 10.1186/s13046-015-0212-z
Read this paper
Zhang Z, Zhou X, Shen H, et al. Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. BMC Med. 2009,7:41. doi: 10.1186/1741-7015-7-41
Read this paper